Consensus Monopar Therapeutics Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:13:42 2024-05-15 pm EDT			5-day change	1st Jan Change
0.643 ^USD	-1.23%		-14.29%	+88.95%

May. 09	Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 16	Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct	MT

c60aca481b5.KmrNWc211oaRf6h6n5zgQIlV9LdFo4INFxGQFkPrACw.GTW4F6bWvPDSEMot9_HNK_Azp5oU8rZGf3D8eCbcMXVbC4QJq9CsyqgR7Q~3dd2eb2302b2135cee91c9e8757dcc39

JonesTrading Upgrades Monopar Therapeutics to Buy From Hold, Price Target is $2	Apr. 11	MT
JonesTrading Downgrades Monopar Therapeutics to Hold From Buy	23-08-10	MT
HC Wainwright Adjusts Monopar Therapeutics' Price Target to $2 From $6, Keeps Buy Rating	23-05-15	MT
Maxim Group Downgrades Monopar Therapeutics to Hold From Buy	23-03-29	MT
Roth MKM Adjusts Price Target on Monopar Therapeutics to $3 From $18, Maintains Buy Rating	23-03-28	MT
EF Hutton Adjusts Price Target on Monopar Therapeutics to $17 From $24, Maintains Buy Rating	23-03-28	MT
Roth Capital Reinstates Monopar Therapeutics at Buy With $18 Price Target	22-12-09	MT
Wall Street Set to Open Lower as Mortgage Rates Climb to 16-Year High	22-10-05	MT
HC Wainwright Adjusts Monopar Therapeutics' Price Target to $6 From $9, Maintains Buy Rating	22-08-16	MT
HC Wainwright Starts Monopar Therapeutics at Buy With $9 Price Target	21-11-01	MT
MONOPAR THERAPEUTICS : Roth Capital Starts Monopar Therapeutics at Buy With $49 Price Target	21-01-28	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.651 USD

Average target price

2.08 USD

Spread / Average Target

+219.51%

High Price Target

2.16 USD

Spread / Highest target

+231.80%

Low Price Target

2 USD

Spread / Lowest Target

+207.22%

JonesTrading Institutional Services
HC Wainwright
Maxim
EF Hutton
Roth MKM
Roth Capital Partners